Back to top

Diagnostic criteria for Substance-Induced Anxiety Disorder

These criteria are obsolete.

DSM Criteria
DSM Version
DSM IV - TR
DSM Criteria

A. Prominent anxiety, Panic Attacks, or obsessions or compulsions predominate in the clinical picture. 

B. There is evidence from the history, physical examination, or laboratory findings of either (1) or (2): 
 (1) the symptoms in Criterion A developed during, or within 1 month of, Substance Intoxication or Withdrawal
 (2) medication use is etiologically related to the disturbance 

C. The disturbance is not better accounted for by an Anxiety Disorder that is not substance induced. Evidence that the symptoms are better accounted for by an Anxiety Disorder that is not substance induced might include the following: the symptoms precede the onset of the substance use (or medication use); the symptoms persist for a substantial period of time (e.g., about a month) after the cessation of acute withdrawal or severe intoxication or are substantially in excess of what would be expected given the type or amount of the substance used or the duration of use; or there is other evidence suggesting the existence of an independent non-substance-induced Anxiety Disorder (e.g., a history of recurrent non-substance-related episodes). 

D. The disturbance does not occur exclusively during the course of a Delirium

E. The disturbance causes clinically significant distress or impairment in social, occupational, or other important areas of functioning. 

Note: This diagnosis should be made instead of a diagnosis of Substance Intoxication or Substance Withdrawal only when the anxiety symptoms are in excess of those usually associated with the intoxication or withdrawal syndrome and when the anxiety symptoms are sufficiently severe to warrant independent clinical attention. 

Code [Specific Substance]-Induced Anxiety Disorder 

(291.8 (new code as of 10/01/96: 291.89) Alcohol; 292.89 Amphetamine (or Amphetamine-Like Substance); 292.89 Caffeine; 292.89 Cannabis; 292.89 Cocaine; 292.89 Hallucinogen; 292.89 Inhalant; 292.89 Phencyclidine (or Phencyclidine-Like Substance); 292.89 Sedative, Hypnotic, or Anxiolytic; 292.89 Other [or Unknown] Substance) 

Specify if: 

With Generalized Anxiety: if excessive anxiety or worry about a number of events or activities predominates in the clinical presentation 
With Panic Attacks: if Panic Attacks predominate in the clinical presentation
With Obsessive-Compulsive Symptoms: if obsessions or compulsions predominate in the clinical presentation 
With Phobic Symptoms: if phobic symptoms predominate in the clinical presentation 
Specify if: 
With Onset During Intoxication: if the criteria are met for Intoxication with the substance and the symptoms develop during the intoxication syndrome 
With Onset During Withdrawal: if criteria are met for Withdrawal from the substance and the symptoms develop during, or shortly after, a withdrawal syndrome

Reprinted with permission from the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Copyright 2000 American Psychiatric Association

DSM Version
DSM IV
DSM Criteria

A. Prominent anxiety, Panic Attacks, or obsessions or compulsions predominate in the clinical picture. 

B. There is evidence from the history, physical examination, or laboratory findings of either (1) or (2): 
 (1) the symptoms in Criterion A developed during, or within 1 month of, Substance Intoxication or Withdrawal
 (2) medication use is etiologically related to the disturbance 

C. The disturbance is not better accounted for by an Anxiety Disorder that is not substance induced. Evidence that the symptoms are better accounted for by an Anxiety Disorder that is not substance induced might include the following: the symptoms precede the onset of the substance use (or medication use); the symptoms persist for a substantial period of time (e.g., about a month) after the cessation of acute withdrawal or severe intoxication or are substantially in excess of what would be expected given the type or amount of the substance used or the duration of use; or there is other evidence suggesting the existence of an independent non-substance-induced Anxiety Disorder (e.g., a history of recurrent non-substance-related episodes). 

D. The disturbance does not occur exclusively during the course of a Delirium

E. The disturbance causes clinically significant distress or impairment in social, occupational, or other important areas of functioning. 

Note: This diagnosis should be made instead of a diagnosis of Substance Intoxication or Substance Withdrawal only when the anxiety symptoms are in excess of those usually associated with the intoxication or withdrawal syndrome and when the anxiety symptoms are sufficiently severe to warrant independent clinical attention. 

Code [Specific Substance]-Induced Anxiety Disorder 

(291.8 (new code as of 10/01/96: 291.89) Alcohol; 292.89 Amphetamine (or Amphetamine-Like Substance); 292.89 Caffeine; 292.89 Cannabis; 292.89 Cocaine; 292.89 Hallucinogen; 292.89 Inhalant; 292.89 Phencyclidine (or Phencyclidine-Like Substance); 292.89 Sedative, Hypnotic, or Anxiolytic; 292.89 Other [or Unknown] Substance) 

Specify if: 

With Generalized Anxiety: if excessive anxiety or worry about a number of events or activities predominates in the clinical presentation 
With Panic Attacks: if Panic Attacks predominate in the clinical presentation
With Obsessive-Compulsive Symptoms: if obsessions or compulsions predominate in the clinical presentation 
With Phobic Symptoms: if phobic symptoms predominate in the clinical presentation 
Specify if: 
With Onset During Intoxication: if the criteria are met for Intoxication with the substance and the symptoms develop during the intoxication syndrome 

With Onset During Withdrawal: if criteria are met for Withdrawal from the substance and the symptoms develop during, or shortly after, a withdrawal syndrome

Reprinted with permission from the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Copyright 1994 American Psychiatric Association